Learn about the ISN’s work in advocacy below.
ISN presence at the World Health Assembly
ISN looks forward to representing the kidney health community at this week’s World Health Assembly in Geneva. Coinciding with the 70th anniversary of the World Health Organization (WHO), this assembly’s program is a busy affair for ISN. Two major agenda points are set to be agreed upon among the WHO member states. This includes the organization’s...
HEARTS: highlighting CKD and CVD prevention
ISN is calling for the implementation of the HEARTS technical package on cardiovascular disease prevention. The World Health Organization and the US Center for Disease Control and Prevention have developed the HEARTS technical package as part of the GLOBAL HEARTS INITIATIVE, of which ISN is a partner. Cardiovascular diseases (CVDs) are the number one cause...
Baxter and ISN collaborate to address growing prevalence of kidney disease
ISN has announced a partnership to advance chronic kidney disease (CKD) awareness and help improve access to therapy, particularly in low- and middle-income countries (LMIC) – commonly referenced as emerging countries – where the disease prevalence is growing the fastest. The collaboration will support greater disease and therapy research and education, as well as work...
Supporting nephrology in Asia Pacific
ISN and the Asian Pacific Society of Nephrology (APSN) have joined forces, building on their common expertise to bridge the gaps that exist in providing valuable care for kidney disease patients across Asia Pacific. Among many sponsorship activities, APSN co-fund several programs every year to increase capacity in East Asia, South Asia, Southeast Asia, and...